Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37901 - 37925 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	MYT1L	23040	downregulated	entinostat results in decreased expression of MYT1L mRNA	2p25.3	A21035
Entinostat	Investigational	MYZAP	100820829	upregulated	entinostat results in increased expression of MYZAP mRNA	15q21.3	A21037
Entinostat	Investigational	N4BP2L1	90634	upregulated	entinostat results in increased expression of N4BP2L1 mRNA	13q13.1	A21037
Entinostat	Investigational	N4BP3	23138	upregulated	entinostat results in increased expression of N4BP3 mRNA	5q35.3	A21037
Entinostat	Investigational	NAALAD2	10003	downregulated	entinostat results in decreased expression of NAALAD2 mRNA	11q14.3	A21037
Entinostat	Investigational	NAB1	4664	downregulated	entinostat results in decreased expression of NAB1 mRNA	2q32.2	A21037
Entinostat	Investigational	NABP1	64859	upregulated	entinostat results in increased expression of NABP1 mRNA	2q32.3	A21035
Entinostat	Investigational	NACC2	138151	upregulated	entinostat results in increased expression of NACC2 mRNA	9q34.3	A21037
Entinostat	Investigational	NADK2	133686	downregulated	entinostat results in decreased expression of NADK2 mRNA	5p13.2	A21037
Entinostat	Investigational	NAGLU	4669	upregulated	entinostat results in increased expression of NAGLU mRNA	17q21.2	A21037
Entinostat	Investigational	NAGS	162417	upregulated	entinostat results in increased expression of NAGS mRNA	17q21.31	A21035
Entinostat	Investigational	NAIP	4671	downregulated	entinostat results in decreased expression of NAIP mRNA	5q13.2	A21037
Entinostat	Investigational	NANOG	79923	upregulated	entinostat results in increased expression of NANOG mRNA	12p13.31	A21037
Entinostat	Investigational	NANS	54187	upregulated	entinostat results in increased expression of NANS mRNA	9q22.33	A21037
Entinostat	Investigational	NAV1	89796	downregulated	entinostat results in decreased expression of NAV1 mRNA	1q32.1	A21037
Entinostat	Investigational	NAV1	89796	upregulated	entinostat results in increased expression of NAV1 mRNA	1q32.1	A21035
Entinostat	Investigational	NBL1	4681	upregulated	entinostat results in increased expression of NBL1 mRNA	1p36.13	A21035
Entinostat	Investigational	NBN	4683	downregulated	entinostat results in decreased expression of NBN mRNA	8q21.3	A21035
Entinostat	Investigational	NBPF10	100132406	downregulated	entinostat results in decreased expression of NBPF10 mRNA	1q21.1	A21037
Entinostat	Investigational	NBPF20	100288142	downregulated	entinostat results in decreased expression of NBPF20 mRNA	1q21.1	A21037
Entinostat	Investigational	NCALD	83988	downregulated	entinostat results in decreased expression of NCALD mRNA	8q22.3	A21037
Entinostat	Investigational	NCEH1	57552	upregulated	entinostat results in increased expression of NCEH1 mRNA	3q26.31	A21035
Entinostat	Investigational	NCLN	56926	upregulated	entinostat results in increased expression of NCLN mRNA	19p13.3	A21037
Entinostat	Investigational	NCOA2	10499	downregulated	entinostat results in decreased expression of NCOA2 mRNA	8q13.3	A21035
Entinostat	Investigational	NCOA7	135112	downregulated	entinostat results in decreased expression of NCOA7 mRNA	6q22.31-q22.32	A21037

Displaying entries 37901 - 37925 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability